137 related articles for article (PubMed ID: 30655218)
1. Factors affecting adenoma detection rate in a national flexible sigmoidoscopy screening programme: a retrospective analysis.
Bevan R; Blanks RG; Nickerson C; Saunders BP; Stebbing J; Tighe R; Veitch AM; Garrett W; Rees CJ
Lancet Gastroenterol Hepatol; 2019 Mar; 4(3):239-247. PubMed ID: 30655218
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial: Flexible sigmoidoscopy as an adjunct to faecal occult blood testing in population screening.
Steele RJ; Carey FA; Stanners G; Lang J; Brand J; Brownlee LA; Crichton EM; Winter JW; Phull PS; Mowat C; Strachan JA; Digan AM; Fraser CG
J Med Screen; 2020 Jun; 27(2):59-67. PubMed ID: 31690179
[TBL] [Abstract][Full Text] [Related]
3. Judgement of the quality of bowel preparation at screening flexible sigmoidoscopy is associated with variability in adenoma detection rates.
Thomas-Gibson S; Rogers P; Cooper S; Man R; Rutter MD; Suzuki N; Swain D; Thuraisingam A; Atkin W
Endoscopy; 2006 May; 38(5):456-60. PubMed ID: 16767579
[TBL] [Abstract][Full Text] [Related]
4. Uptake of Bowel Scope (Flexible Sigmoidoscopy) Screening in the English National Programme: the first 14 months.
McGregor LM; Bonello B; Kerrison RS; Nickerson C; Baio G; Berkman L; Rees CJ; Atkin W; Wardle J; von Wagner C
J Med Screen; 2016 Jun; 23(2):77-82. PubMed ID: 26387824
[TBL] [Abstract][Full Text] [Related]
5. Depth of insertion at flexible sigmoidoscopy: implications for colorectal cancer screening and instrument design.
Painter J; Saunders DB; Bell GD; Williams CB; Pitt R; Bladen J
Endoscopy; 1999 Mar; 31(3):227-31. PubMed ID: 10344426
[TBL] [Abstract][Full Text] [Related]
6. Female gender and other factors predictive of a limited screening flexible sigmoidoscopy examination for colorectal cancer.
Eloubeidi MA; Wallace MB; Desmond R; Farraye FA
Am J Gastroenterol; 2003 Jul; 98(7):1634-9. PubMed ID: 12873591
[TBL] [Abstract][Full Text] [Related]
7. Colonoscopy conversion after flexible sigmoidoscopy screening: results from the UK Bowel Scope Screening Programme.
Siau K; Yew AC; Ishaq S; Jewes S; Shetty S; Brookes M; Veitch A; McKaig B; Murugananthan A
Colorectal Dis; 2018 Jun; 20(6):502-508. PubMed ID: 29205835
[TBL] [Abstract][Full Text] [Related]
8. Flexible sigmoidoscopy following a positive faecal occult blood test within a bowel screening programme may reduce the detection of neoplasia.
Mansouri D; McMillan DC; Roxburgh CS; Moug SJ; Crighton EM; Horgan PG
Colorectal Dis; 2013 Nov; 15(11):1375-81. PubMed ID: 23927751
[TBL] [Abstract][Full Text] [Related]
9. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme.
Lee TJ; Rutter MD; Blanks RG; Moss SM; Goddard AF; Chilton A; Nickerson C; McNally RJ; Patnick J; Rees CJ
Gut; 2012 Jul; 61(7):1050-7. PubMed ID: 21940723
[TBL] [Abstract][Full Text] [Related]
10. Difficult or incomplete flexible sigmoidoscopy: implications for a screening programme.
Stewart BT; Keck JO; Duncan AV; Santamaria NM; Allen P
Aust N Z J Surg; 1999 Jan; 69(1):19-21. PubMed ID: 9932914
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study.
Buskermolen M; Cenin DR; Helsingen LM; Guyatt G; Vandvik PO; Haug U; Bretthauer M; Lansdorp-Vogelaar I
BMJ; 2019 Oct; 367():l5383. PubMed ID: 31578177
[TBL] [Abstract][Full Text] [Related]
12. WASh multicentre randomised controlled trial: water-assisted sigmoidoscopy in English NHS bowel scope screening.
Rutter MD; Evans R; Hoare Z; Von Wagner C; Deane J; Esmaily S; Larkin T; Edwards R; Yeo ST; Spencer LH; Holmes E; Saunders BP; Rees CJ; Tsiamoulos ZP; Beintaris I;
Gut; 2021 May; 70(5):845-852. PubMed ID: 32895334
[TBL] [Abstract][Full Text] [Related]
13. Multi-step validation of a deep learning-based system for the quantification of bowel preparation: a prospective, observational study.
Zhou W; Yao L; Wu H; Zheng B; Hu S; Zhang L; Li X; He C; Wang Z; Li Y; Huang C; Guo M; Zhang X; Zhu Q; Wu L; Deng Y; Zhang J; Tan W; Li C; Zhang C; Gong R; Du H; Zhou J; Sharma P; Yu H
Lancet Digit Health; 2021 Nov; 3(11):e697-e706. PubMed ID: 34538736
[TBL] [Abstract][Full Text] [Related]
14. BowelScope: Accuracy of Detection Using Endocuff Optimisation of Mucosal Abnormalities (the B-ADENOMA Study): a multicentre, randomised controlled flexible sigmoidoscopy trial.
Rees CJ; Brand A; Ngu WS; Stokes C; Hoare Z; Totton N; Bhandari P; Sharp L; Bastable A; Rutter MD; Verma AM; Lee TJ; Walls M;
Gut; 2020 Nov; 69(11):1959-1965. PubMed ID: 32245908
[TBL] [Abstract][Full Text] [Related]
15. The first 3 years of national bowel cancer screening at a single UK tertiary centre.
Gupta S; Saunders BP; Fraser C; Kennedy RH; Ignjatovic A; Sala S; Marshall S; Suzuki N; Vance M; Thomas-Gibson S
Colorectal Dis; 2012 Feb; 14(2):166-73. PubMed ID: 21689280
[TBL] [Abstract][Full Text] [Related]
16. Population based randomized study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing.
Verne JE; Aubrey R; Love SB; Talbot IC; Northover JM
BMJ; 1998 Jul; 317(7152):182-5. PubMed ID: 9665902
[TBL] [Abstract][Full Text] [Related]
17. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.
Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Church T; Yurgalevitch S; Austin JH; Prorok PC; Gohagan JK;
J Natl Cancer Inst; 2005 Jul; 97(13):989-97. PubMed ID: 15998952
[TBL] [Abstract][Full Text] [Related]
18. The impact of endoscopist performance and patient factors on distal adenoma detection and colorectal cancer incidence.
Power S; Wooldrage K; Saunders BP; Cross AJ
BMC Gastroenterol; 2024 Jan; 24(1):44. PubMed ID: 38262960
[TBL] [Abstract][Full Text] [Related]
19. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial.
Miller EA; Pinsky PF; Schoen RE; Prorok PC; Church TR
Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):101-110. PubMed ID: 30502933
[TBL] [Abstract][Full Text] [Related]
20. Colorectal Cancer Screening With Repeated Fecal Immunochemical Test Versus Sigmoidoscopy: Baseline Results From a Randomized Trial.
Randel KR; Schult AL; Botteri E; Hoff G; Bretthauer M; Ursin G; Natvig E; Berstad P; Jørgensen A; Sandvei PK; Olsen ME; Frigstad SO; Darre-Næss O; Norvard ER; Bolstad N; Kørner H; Wibe A; Wensaas KA; de Lange T; Holme Ø
Gastroenterology; 2021 Mar; 160(4):1085-1096.e5. PubMed ID: 33227280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
